We develop a product for the detection of peroxide-based explosives for the homeland security market. We were incorporated under the laws of the State of Nevada on May 22, 2002 under the name of Medina International Corp. On May 4, 2006, we changed our name to ACRO Inc. We effected this change of name by merging our company with a wholly owned subsidiary of our company that we had formed specifically for this purpose. We have a wholly owned subsidiary, Acrosec Ltd., which is incorporated under the laws of the State of Israel. Our principal executive and head office is located at 37 Inbar St., Caesarea, Israel.

Initially, our business has been to provide professional consulting services for the technical and economic evaluation of petroleum and natural gas resources.

Since, we were not successful in fully implementing our initial business plan for the consulting services, we have decided to no longer offer consulting services to oil and gas companies. Accordingly, on March 15, 2006, we completed our acquisition of a patent pursuant to a patent purchase agreement with Dr. Ehud Keinan, which we refer here as the Patent Purchase Agreement. The patent, U.S. Patent No. 6,767,717, describes an invention that provides a method of detection of peroxide based explosives. Through a consulting services agreement that we signed at the same time, Dr. Ehud Keinan, the inventor of the method described in the patent, has agreed to provide consulting services to us in order to develop the patent into a commercially viable product.

On January 19, 2006, we closed a private placement consisting of 20,200,012 shares of common stock for total gross proceeds of $43,286 in the form of a promissory note payable upon demand, in which two of our current directors, Gadi Aner and Ehud Keinan, who were not directors at that time, and Zeev Bronfeld, beneficial owner of more than 5% of our common stock participated. Pursuant to the private placement, we issued, among others: (i) 2,300,004 shares of common stock to Gadi Aner for a total consideration of US$4,929; (ii) 2,800,000 Shares to M.G-Net Ltd., a private company, wholly-owned by Mr. Aner and his wife, for a total consideration of US$6,000; and (iii) 6,400,002 shares of common stock to BioTech Knowledge LLC, a private company wholly-owned by Ehud Keinan, for a total consideration of $13,714. In addition, pursuant to a share purchase agreement dated January 10, 2006, two of our former directors, Nick DeMare and Brad Colby, sold their entire interests in us, 14,000,000 shares of common stock, to BioTech Knowledge LLC. As a result of these two transactions, BioTech Knowledge LLC is our largest stockholders with approximately 30.38% of our common stock.